http://rdf.ncbi.nlm.nih.gov/pubchem/patent/SU-1379741-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3e1459296b6fbd5ec39cd65694736510 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-84 |
| filingDate | 1986-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1988-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d201d0f3f0a8743db0e3be0e82a3c1a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3cfaec086bfca210d16f30ff26f3d10b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e16a7d2b644a3f4ea1218c4def2b36f7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f93bb06c0eff3ea44793cfb143d2cbd5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c9f8c0ca73be6bb7adf60d3728f1255 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a83a58c24cc94c92cb594b3ccecbbe2 |
| publicationDate | 1988-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | SU-1379741-A1 |
| titleOfInvention | Method of diagnosing postmenopausal osteoporosis |
| abstract | The invention relates to medicine, more precisely to. Gynecological endocrinology, intended for the diagnosis of postmenopausal osteoporosis. For this, daily urine is collected. A trilonometric titration was performed under the control of a photoelectrocolorimeter using murexide as an indicator; the amount of calcium in the daily urine was determined. At a rate of 2.5–5.75 mmol / day or a reduced rate (2.5 mmol / day), the daily calcium excretion with mozza is prescribed to patients, 2 μg of 1- (ок-сихсих ле) –calciferol daily for 3-4 days. On the 4th day, the calcium content in the daily urine is again determined. Tc-oxycholecalciferol is continued to be treated with simultaneous administration of 0.025 mg of ethinyl estradiol daily for 6-7 days. The daily excretion of calcin with urine is then determined again. By lowering it. level of estrogen administration. 2-5 mmol in relation to the daily excretion of calcium in the urine after 1 - c / - oxycholenic calcification is diagnosed with postmenopausal osteoporosis in the presence of an appropriate clinic. € (L |
| priorityDate | 1986-03-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 23.